Finnegan A - Search Results

1

Acute xenograft rejection mediated by antibodies produced independently of TH1/TH2 cytokine profiles.

Dujovny N, Varghese A, Shen J, Yin D, Ji S, Ma L, Finnegan A, Chong AS. Dujovny N, et al. Among authors: finnegan a. Am J Transplant. 2002 Jul;2(6):526-34. doi: 10.1034/j.1600-6143.2002.20606.x. Am J Transplant. 2002. PMID: 12118896 Free article.

2

In vitro and in vivo mechanisms of action of the antiproliferative and immunosuppressive agent, brequinar sodium.

Xu X, Williams JW, Shen J, Gong H, Yin DP, Blinder L, Elder RT, Sankary H, Finnegan A, Chong AS. Xu X, et al. Among authors: finnegan a. J Immunol. 1998 Jan 15;160(2):846-53. J Immunol. 1998. PMID: 9551920

3

Regulation of B cell function by the immunosuppressive agent leflunomide.

Siemasko KF, Chong AS, Williams JW, Bremer EG, Finnegan A. Siemasko KF, et al. Among authors: finnegan a. Transplantation. 1996 Feb 27;61(4):635-42. doi: 10.1097/00007890-199602270-00020. Transplantation. 1996. PMID: 8610393

4

Leflunomide, a novel immunosuppressive agent. The mechanism of inhibition of T cell proliferation.

Chong AS, Finnegan A, Jiang X, Gebel H, Sankary HN, Foster P, Williams JW. Chong AS, et al. Among authors: finnegan a. Transplantation. 1993 Jun;55(6):1361-6. doi: 10.1097/00007890-199306000-00028. Transplantation. 1993. PMID: 8390735

5

Inhibition of protein tyrosine phosphorylation in T cells by a novel immunosuppressive agent, leflunomide.

Xu X, Williams JW, Bremer EG, Finnegan A, Chong AS. Xu X, et al. Among authors: finnegan a. J Biol Chem. 1995 May 26;270(21):12398-403. doi: 10.1074/jbc.270.21.12398. J Biol Chem. 1995. PMID: 7759480 Free article.

6

Effects of leflunomide and other immunosuppressive agents on T cell proliferation in vitro.

Chong AS, Rezai K, Gebel HM, Finnegan A, Foster P, Xu X, Williams JW. Chong AS, et al. Among authors: finnegan a. Transplantation. 1996 Jan 15;61(1):140-5. doi: 10.1097/00007890-199601150-00026. Transplantation. 1996. PMID: 8560553

7

Inhibition of JAK3 and STAT6 tyrosine phosphorylation by the immunosuppressive drug leflunomide leads to a block in IgG1 production.

Siemasko K, Chong AS, Jäck HM, Gong H, Williams JW, Finnegan A. Siemasko K, et al. Among authors: finnegan a. J Immunol. 1998 Feb 15;160(4):1581-8. J Immunol. 1998. PMID: 9469413

8

Cutting edge: Cbl-b: one of the key molecules tuning CD28- and CTLA-4-mediated T cell costimulation.

Li D, Gál I, Vermes C, Alegre ML, Chong AS, Chen L, Shao Q, Adarichev V, Xu X, Koreny T, Mikecz K, Finnegan A, Glant TT, Zhang J. Li D, et al. Among authors: finnegan a. J Immunol. 2004 Dec 15;173(12):7135-9. doi: 10.4049/jimmunol.173.12.7135. J Immunol. 2004. PMID: 15585834

9

In vivo mechanism by which leflunomide controls lymphoproliferative and autoimmune disease in MRL/MpJ-lpr/lpr mice.

Xu X, Blinder L, Shen J, Gong H, Finnegan A, Williams JW, Chong AS. Xu X, et al. Among authors: finnegan a. J Immunol. 1997 Jul 1;159(1):167-74. J Immunol. 1997. PMID: 9200452

10

Two activities of the immunosuppressive metabolite of leflunomide, A77 1726. Inhibition of pyrimidine nucleotide synthesis and protein tyrosine phosphorylation.

Xu X, Williams JW, Gong H, Finnegan A, Chong AS. Xu X, et al. Among authors: finnegan a. Biochem Pharmacol. 1996 Aug 23;52(4):527-34. doi: 10.1016/0006-2952(96)00303-6. Biochem Pharmacol. 1996. PMID: 8759024

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

203 results

Search Page

Filters